Allogeneic cell vaccine (University of Kentucky)
异基因型细胞疫苗（肯塔基大学）
Report date: 2022/07/20 10:11:26
Base Information
Drug NameAllogeneic cell vaccine (University of Kentucky)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kentucky
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Of Louisville
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A